A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.

Academic Article


Published In


  • African Americans, Anticoagulants, Aryl Hydrocarbon Hydroxylases, Atrial Fibrillation, Comorbidity, Cytochrome P-450 CYP2C9, DNA Mutational Analysis, Gastrointestinal Hemorrhage, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Sequence Analysis, DNA, Warfarin
  • Digital Object Identifier (doi)

    Author List

  • Goldstein JA; Blaisdell JA; Limdi NA
  • Start Page

  • 155
  • End Page

  • 158
  • Volume

  • 42
  • Issue

  • 2